Eye pressure of patients undergoing intravitreal injection of bevacizumab. Glaucoma secondary to drugs
Conditions
Interventions
Intervention 1: Intervention group: In the first group, 0.5% topical timolol drops (2 drops with a 10-minute interval, 60-90 minutes before the intervention) are prescribed. Intervention 2: Interventi
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1- Age more than 18 years 2- Informed and free consent to participate in the study 3- Patients who will have the first intra-boasizomat injection.
Exclusion criteria
Exclusion criteria: 1- History of retinal surgery. 2- Rupture of the posterior capsule 3- High eye pressure or glaucoma 4- Use of topical medication (such as IOP-lowering medications and corticosteroids) 5- Active intraocular inflammation 6- Eye pathologies such as pterygium or corneal opacities that can affect the evaluation of study variables 7- Withdrawal from the study during research for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: The beginning of the study / one minute after injection / 30 minutes after injection / 24 hours after injection. Method of measurement: At the beginning of the study, 30 minutes after the injection and 24 hours after the injection, the intraocular pressure is measured with a Goldman tonometer and one minute after the injection with Tonopen. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMr. Dr. Mohammad Erish
Zahedan University of Medical Sciences
Outcome results
None listed